Borosil Scientific Q2 Profit Rises 86% to Rs 5.3 Crore

Borosil Scientific Limited reported consolidated profit after tax of Rs 5.3 crore in Q2FY27, an 86.3% increase from Rs 2.9 crore a year earlier. The improvement came as consolidated net sales rose 7.5% to Rs 115.0 crore and Goel Glass Works Scientific Limited substantially narrowed its loss before tax.

What did Borosil Scientific report for Q2FY27?

Borosil Scientific reported consolidated net sales of Rs 115.0 crore for the quarter ended September 30, 2026, compared with Rs 106.9 crore in Q2FY26. The 7.5% year-on-year increase in sales was accompanied by a rise in consolidated EBITDA to Rs 11.0 crore from Rs 8.5 crore.

Consolidated EBITDA margin improved to 9.6% from 8.0% in the corresponding quarter of the previous financial year. Consolidated profit before tax increased 49.5% to Rs 7.7 crore, compared with Rs 5.1 crore a year earlier. Profit after tax rose to Rs 5.3 crore from Rs 2.9 crore.

The quarterly outcome is notable because the improvement at the consolidated level was stronger than the performance of the standalone business. The company attributed the consolidated profit growth to stronger sales and operations at its subsidiary, Goel Glass Works Scientific Limited.

Why did consolidated profit increase despite weaker standalone earnings?

The main factor behind the consolidated improvement was a narrower loss at Goel Glass Works Scientific. The subsidiary recorded a loss before tax of Rs 1.1 crore in Q2FY27, compared with a loss before tax of Rs 4.8 crore in Q2FY26.

This reduction in the subsidiary's loss supported the group's consolidated earnings even as Borosil Scientific's standalone profitability declined. The reported figures show that the subsidiary's operational improvement had a material effect on the difference between standalone and consolidated results.

The company did not provide an earnings-call transcript for the quarter in the supplied information. As a result, the available explanation is limited to the investor presentation, which links the consolidated improvement to stronger sales and operations at Goel Glass Works Scientific.

How did Borosil Scientific's standalone business perform?

Borosil Scientific's standalone net sales increased 4.7% to Rs 104.2 crore in Q2FY27 from Rs 99.5 crore in Q2FY26. However, standalone EBITDA declined 9.7% to Rs 11.7 crore from Rs 13.0 crore.

Standalone EBITDA margin fell to 11.3% from 13.1% a year earlier. Standalone profit after tax declined 16.9% to Rs 6.2 crore, compared with Rs 7.5 crore in Q2FY26. These figures indicate that sales growth did not translate into higher standalone earnings during the quarter.

Management said standalone profitability is expected to improve as the Middle East situation stabilises. It also said it is taking initiatives to reduce the impact, though the presentation did not specify the financial value of those measures or a timetable for their effect.

The company further noted that Q2FY27 EBITDA and EBIT exclude investment income of Rs 2.1 crore. This disclosure is relevant when comparing operating performance with reported profit measures, as the investment income was not included in those operating metrics.

What expansion plan has Borosil Scientific disclosed?

Borosil Scientific has proposed a significant expansion of its glassware production capacity. The company has indicated that capacity could rise from about 15 lakh units a year to about 108 lakh units a year.

Commercial production from the proposed expansion is expected in March 2027. The disclosed information also lists capex of Rs 60 crore, although the supplied material does not provide a detailed project-wise allocation or an updated spending schedule.

The expansion plan provides context for the company's focus on scaling its manufacturing base. Its execution will be relevant to future operating capacity, but the current quarterly results only establish the reported sales, profitability and subsidiary performance for Q2FY27.

How do the Q2FY27 results affect investors and operations?

For investors, the quarter presents two distinct trends. Consolidated profit, EBITDA and margins improved, supported by the reduced loss at Goel Glass Works Scientific, while standalone profit and operating margin declined despite growth in standalone sales.

The figures also show that subsidiary performance played an important role in the consolidated outcome. A reduction in the subsidiary's loss before tax from Rs 4.8 crore to Rs 1.1 crore helped offset pressure in the standalone business and lifted group-level profitability.

For operations, management's reference to the Middle East situation identifies an external factor affecting standalone profitability. The company has not quantified the impact, nor has it set out a timetable for the initiatives intended to limit it. The planned capacity expansion remains another important operational development ahead of the March 2027 commercial-production target.

Conclusion

Borosil Scientific delivered a stronger consolidated Q2FY27, with profit after tax rising 86.3% to Rs 5.3 crore and EBITDA margin improving to 9.6%. The key driver was the substantial narrowing of Goel Glass Works Scientific's loss, while the standalone business reported lower EBITDA, margin and profit.

Investors will watch for progress in standalone profitability as the Middle East situation evolves, as well as execution of the glassware capacity expansion. The company has targeted commercial production from the expanded capacity in March 2027, while details of its mitigation initiatives and capex allocation remain undisclosed.